Genital human papillomavirus (HPV) infection is very common, and often sub-clinical and
usually resolves without any treatment. Genital warts are caused by HPV 6/11 infection and …

Imiquimod 5% cream is approved for the topical treatment of external anogenital warts
caused by human papillomavirus (HPV) and for the skin cancer conditions superficial basal …

Background The placebo arm of human papillomavirus (HPV) vaccine trials helps define the
natural history of genital warts (GW) Methods Women enrolled in the placebo arm (n= 8800) …

Intratumoral immune activation can induce local and systemic antitumor immunity.
Imiquimod is a cream-formulated, TLR7 agonist that is Food and Drug Administration …

The latest edition of Pediatric Dermatology, edited by Lawrence A. Schachner, MD and
Ronald C. Hansen, MD brings you the detailed guidance you need to effectively diagnose …

Background Anogenital warts (AGW) can cause economic burden on healthcare systems
and are associated with emotional, psychological and physical issues. Objective To provide …

Human Papillomaviruses (HPV) are double‐stranded DNA viruses, which result in a variety
of clinical manifestations according to type. The most common cutaneous lesions include …

Imiquimod : Current Opinion in Infectious Diseases Imiquimod : Current Opinion in Infectious
Diseases Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …

Objective Clinical efficacy and safety of Polyphenon® E, a defined green tea extract, in
external genital warts. Design Randomized, double‐blind, placebo‐controlled study for up to …

Topical Imiquimod 5% Cream as an Effective Treatment for Ext... : Sexually Transmitted Diseases
Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts …